BioTech Medics, Inc. Negotiating SHBAN(TM) Non-Alcohol Hand Sanitizer Brazil Distribution Agreement
October 13 2009 - 8:58AM
Marketwired
BioTech Medics, Inc. (PINKSHEETS: BMCS) announced today that it is
finalizing a wholesaler Distribution Agreement for BioTech's
SHBAN(TM) Antimicrobial Non-Alcohol Hand Sanitizer Products with a
Brazil distributor. The final agreement is expected to be signed by
Friday, October 16. The initial income and fees to BioTech for 2009
for the Brazil Distributorship is $500,000 (US) and projected
$2,500,000 (US) in sales for 2010.
SHBAN is manufactured at an FDA registered plant. It is a
bio-degradable product superior to most anti-bacterial hand
sanitizers because 1) SHBAN is longer lasting; 2) SHBAN does NOT
contain alcohol or alcohol gel which has poisoned over 22,000
children; 3) SHBAN is non-toxic when used as directed on humans; 4)
SHBAN is non-staining; 5) SHBAN is non-flammable; and 6) SHBAN
contains no ammonia, bleach, Benzalkonium Chloride (BOC), nor
Triclosan®, nor thymus vulgaris (which is a potent carcinogen for
rodents) or fragrance ingredients. Most hand sanitizer products
cannot make all of these claims.
SHBAN is protected under US Letters of Patent #5,514,808,
#5,574,050, #5,679,711 and #5,585,391 and a patent pending for the
US and international patent. SHBAN is a trademark of BioTech
Medics, Inc. BioTech is negotiating more foreign distributorships
and will be announcing the signing of additional distributorships
soon.
SHBAN(TM) in previous in vitro and in vivo testing has been
evaluated for its antimicrobial properties against Staph. Aureus,
Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Prior
clinical studies have been conducted at the University of Texas
Medical Branch, Galveston, TX; Microbiology & Biochemical Assay
Laboratories - Houston, TX; Pathology Associates, Pasadena, TX;
Texas A & M University - College of Veterinary Medicine,
College Station, TX; Baylor College of Dentistry, Dallas, TX;
Allergan, Irvine, CA; Culleen Eye Institute, Baylor College of
Medicine, Houston, TX.
BioTech is completing independent clinical testing of SHBAN(TM)
Hand Sanitizer Solution to determine if it reduces (or kills) the
H1N1 (Swine) Influenza A virus.
Interested parties desiring a SHBAN Distributorship should
contact BioTech immediately.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995
(the "Act"). The statements above have not been evaluated by the
FDA. SHBAN is not intended to diagnose, treat or cure any
disease.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Tom Wood Sr. V.P. Sales Phone 972-849-3782
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jul 2023 to Jul 2024